Trials / Unknown
UnknownNCT04258735
Genetic Characteristics of Metastatic Breast Cancer Patients
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 300 (estimated)
- Sponsor
- Samsung Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Genomic analysis for metastatic breast cancer(MBC) patients * Participant (Inclusion criteria) 1. Patients who diagnosed metastatic/stage IV breast cancer 2. Patients who were not received treatment for metastatic breast cancer on palliative setting * Process (1) Tissue/ Blood sample * At diagnosis, MBC tissue / blood sample (20cc) will be obtained. * At disease progression after 1st line treatment for MBC, blood sample (20cc) will be obtained (tissue; optional) (2) WES, RNASeq, ctDNA, Exosome * We will analyze genomic characteritics using WES, RNASeq, ctDNA, Exosome.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Genomic analysis | WES, RNASeq, ctDNA, Exosome |
Timeline
- Start date
- 2019-07-17
- Primary completion
- 2024-07-31
- Completion
- 2024-07-31
- First posted
- 2020-02-06
- Last updated
- 2020-02-06
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04258735. Inclusion in this directory is not an endorsement.